SCHEMBL30701209

SCHEMBL30701209

Nc1c(C(=O)O)sc2nc(-c3cccs3)cc(-c3ccccc3)c12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 15/20 0.71
MAPT P10636 9/20 0.67
KDM4E B2RXH2 6/20 0.67
ALDH1A1 P00352 6/20 0.67
KMT2A Q03164 6/20 0.67
MEN1 O00255 5/20 0.67
NPSR1 Q6W5P4 3/20 0.67
RXFP1 Q9HBX9 2/20 0.67
POLB P06746 1/20 0.67
ALOX15 P16050 1/20 0.67
TSHR P16473 1/20 0.67
MAPK1 P28482 1/20 0.67
CASP1 P29466 1/20 0.67
CASP7 P55210 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
HSD17B10 Q99714 1/20 0.67
TDP1 Q9NUW8 1/20 0.67
L3MBTL1 Q9Y468 1/20 0.65
USP2 O75604 1/20 0.62
HIF1A Q16665 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15583810 1.00 HPGD (0.71) HPGDMAPTKDM4EALDH1A1KMT2A
SCHEMBL27473523 0.92 HPGD (0.70) HPGDMAPTKDM4EALDH1A1KMT2A
SCHEMBL27475606 0.91 MAPT (0.67) HPGDMAPTKDM4EALDH1A1KMT2A
SCHEMBL6216343 0.90 HPGD (0.68) HPGDMAPTKDM4EALDH1A1KMT2A
SCHEMBL16557518 0.88 HPGD (0.71) HPGDMAPTKDM4EALDH1A1KMT2A
SCHEMBL21589903 0.87 HPGD (0.65) HPGDMAPTKDM4EALDH1A1KMT2A
SCHEMBL6217262 0.86 MAPT (0.86) HPGDMAPTKDM4EALDH1A1KMT2A
SCHEMBL15583949 0.85 HPGD (0.93) HPGDMAPTKDM4EALDH1A1KMT2A
SCHEMBL6215605 0.85 ALDH1A1 (0.73) HPGDMAPTKDM4EALDH1A1KMT2A
SCHEMBL30701120 0.85 HPGD (0.93) HPGDMAPTKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043443-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY UNIV CASE WESTERN RESERVE (US) 2024-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240043443-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS HPGD 2/4885MAPT 4311/4885KDM4E 3434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.